Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
»
Sanofi gears up for approval of its BTK inhibitor, meets Phase III endpoint
Clinical Trials Arena
Tue, 04/23/24 - 10:51 am
Sanofi
rilzabrutinib
Btk inhibitors
ITP
Oncologists' meetings with drug reps don't help cancer patients live longer
NPR
Tue, 04/23/24 - 10:49 am
oncologists
patients
cancer
drug reps
pharma marketing
Exactech recalls shoulder devices after initially declining to act
Medtech Dive
Tue, 04/23/24 - 10:41 am
Medtech
Exactech
shoulder implants
device recalls
FDA
Vistagen’s on-demand nasal spray could provide a novel option for social anxiety
Pharma Voice
Tue, 04/23/24 - 10:40 am
Vistage
fasedienol
social anxiety
Drug distributor Cardinal Health to lose OptumRx contracts
Reuters
Tue, 04/23/24 - 10:40 am
Cardinal Health
OptumRx
Unitedhealth Group
Big Pharma market caps surge to start 2024 despite economic headwinds
Medical Marketing and Media
Tue, 04/23/24 - 10:38 am
Big Pharma
market cap
Novo Nordisk
Eli Lilly
BenevolentAI lays off 30% of staff, exits US site as funding gap looms
Fierce Biotech
Tue, 04/23/24 - 10:35 am
BenevolentAI
drug development
layoffs
Inside J&J’s strategy to de-gender clinical trials
Pharma Voice
Tue, 04/23/24 - 10:33 am
clinical trials
LGBTQ+
clinical trial diversity
JNJ
ImmunityBio bags FDA approval for Anktiva to challenge Merck in bladder cancer
Fierce Pharma
Tue, 04/23/24 - 10:32 am
ImmunityBio
immunotherapy
FDA
anktiva
Patrick Soon-Shiong
Pfizer vs Moderna battle over COVID vaccine patents begins in UK
Reuters
Tue, 04/23/24 - 10:30 am
Pfizer
BioNTech
Moderna Therapeutics
COVID-19
patents
vaccines
legal
Novartis names ex-BMS CEO Caforio as chair amid strong Q1
Pharmaphorum
Tue, 04/23/24 - 10:29 am
Novartis
earnings
Giovanni Caforio
Bristol Myers Squibb
Bristol Myers taps startup to boost cell therapy production
BioPharma Dive
Mon, 04/22/24 - 06:06 pm
Bristol Myers Squibb
drug manufacturing
cell therapy
Cellares
Ahead of Alnylam's key heart disease readout, experts say Pfizer rival would be hard to displace
Fierce Pharma
Mon, 04/22/24 - 06:01 pm
Alnylam
Pfizer
Amvuttra
ATTR-CM
tafamidis
Sanofi's Zantac settlement is worth $100M, or $25K per claimant: Bloomberg
Fierce Pharma
Mon, 04/22/24 - 05:59 pm
Sanofi
legal
Zantac
settlements
Patients Fare Better With Women Doctors, Study Finds
Forbes
Mon, 04/22/24 - 05:55 pm
physicians
doctors
women
Lilly to buy injectable drug plant in manufacturing ramp-up
BioPharma Dive
Mon, 04/22/24 - 05:54 pm
Eli Lilly
drug manufacturing
Mounjaro
Zepbound
Wisconsin
Bayer confirms 2024 outlook despite slow start for agriculture, consumer health units
Reuters
Mon, 04/22/24 - 05:52 pm
Bayer
earnings
consumer health
Breast Cancer Detection Drug-Device System Nabs FDA Approval
Medical Devices and Diagnostics Industry
Mon, 04/22/24 - 05:51 pm
Medtech
Lumicell
FDA
Limisight
optical imaging
breast cancer
diagnostics
Eisai hunts for next Alzheimer’s drug with new research pact
BioPharma Dive
Mon, 04/22/24 - 05:49 pm
Eisai
R&D
Alzheimer's disease
BioArctic
April 22 2024 - AbbVie tops doctor ranking of immunology companies, handily beating Pfizer and J&J
Mon, 04/22/24 - 11:49 am
Pages
« first
‹ previous
…
3
4
5
6
7
8
9
10
11
…
next ›
last »